ONC
BeOne Medicines Ltd. · Healthcare · Market cap $568.3B
Insiders sold $268.9M net in the last 90 days ·6 sellers, 0 buyers· 15 of 18 sales under Rule 10b5-1 plans· latest Form 4 filed Oct 15, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$380.0M
reported sales (SEC code S)
Unique Insiders
12
in the rolling window
Latest filing
Oct 15, 2026
Wang Xiaodong
BeOne Medicines Ltd. (ONC) has 69 SEC Form 4 filings (284 transaction rows) in the rolling window, disclosed by 12 distinct insiders. Most recent filing: Oct 15, 2026.
Inside the rolling window, 12 insiders at BeOne Medicines Ltd. reported no open-market purchases and 59 open-market sales totaling $380.0M. The most active filer is Chief Executive Officer OYLER JOHN with 17 filings. Insiders have net sold $339.5M over the trailing 6 months. The most recent open-market filing is a sale of 31,027 shares by Director Wang Xiaodong, dated Oct 13, 2026, worth $10.9M.
- Industry:Biotechnology
- CEO:John V. Oyler
- Employees:12,000
- HQ:Basel, PA, CH
- IPO:2016-02-03
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chair, Scientific Advisory Brd | Sale | 31,027 | $10.9M | Oct 15 | +2.8% | SEC ↗ | |
| SVP, General Counsel | Sale | 1,115 | $418K | Oct 2 | +7.4% | SEC ↗ | |
| Chair, Scientific Advisory Brd | Sale | 31,028 | $11.3M | Sep 30 | +5.1% | SEC ↗ | |
Wang XiaodongFirst filing | Chair, Scientific Advisory Brd | Sale | 38,287 | $13.4M | Sep 10 | — | SEC ↗ |
| Principal Accounting Officer | Sale | 132 | $47K | Sep 3 | — | SEC ↗ | |
| President and COO | Sale | 280 | $106K | Aug 27 | — | SEC ↗ | |
| SVP, General Counsel | Sale | 2,666 | $960K | Aug 14 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 115,011 | $41.2M | Aug 12 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 70,907 | $25.7M | Aug 12 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 54,892 | $19.7M | Aug 12 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 1,157 | $362K | Aug 5 | — | SEC ↗ | |
| SVP, General Counsel | Sale | 1,044 | $338K | Aug 3 | — | SEC ↗ | |
| SVP, General Counsel | Sale | 1,669 | $542K | Jul 24 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 48,316 | $15.1M | Jul 22 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 61,397 | $19.5M | Jul 22 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 116,557 | $36.4M | Jul 17 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 166,597 | $53.0M | Jul 17 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 64,628 | $20.2M | Jul 17 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 145,861 | $44.6M | Jul 15 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 11,698 | $3.5M | Jul 15 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 48,520 | $14.8M | Jul 15 | — | SEC ↗ | |
| SVP, General Counsel | Sale | 664 | $201K | Jul 10 | — | SEC ↗ | |
| Chief Executive Officer | Sale | 3,410 | $934K | Jun 25 | — | SEC ↗ | |
| President and COO | Sale | 1,292 | $357K | Jun 25 | — | SEC ↗ | |
| President, Global Head of R&D | Sale | 1,068 | $296K | Jun 25 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does ONC have?
BeOne Medicines Ltd. (ONC) has 69 SEC Form 4 filings (284 transaction rows) in the rolling 365-day window, disclosed by 12 distinct insiders. Most recent filing: Oct 15, 2026.
When was the most recent SEC Form 4 filing for ONC?
The most recent Form 4 filing for ONC on Tracefour is dated Oct 15, 2026.
Who is the most active insider at ONC?
The most active SEC Form 4 filer at ONC in the rolling window is Chief Executive Officer OYLER JOHN, with 17 filings.
What is the net insider flow at ONC over the last 6 months?
Over the trailing 180 days, insiders at ONC have net sold $339.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at ONC in the current window?
Inside the rolling window, insiders at ONC bought $0 and sold $380.0M based on SEC Form 4 filings.
Can I get alerts for ONC insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at BeOne Medicines Ltd. (ONC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
BeOne Medicines Ltd. is in the Healthcare sector.